Scientists are getting closer to building life from scratch and technology pioneers are taking notice, with record sums moving into a field that could deliver novel drugs, materials, chemicals and even perfumes. Despite ethical and safety concerns, investors are attracted by synthetic biology’s wide market potential and the plummeting cost of DNA synthesis, which is industrializing the writing of the genetic code that determines how organisms function.
Thursday, April 06, 2017
How artificial life spawned a billion-dollar industry
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment